BDD Pharma is a world class drug delivery company. We help our clients with unique drug delivery challenges by using clinical tools to formulate innovative modified release products. Our clients can accelerate their product development pipelines with adaptive clinical trials, which consists of formulation development, GMP manufacture and clinical trial management; providing in vivo clinical data in as short as 6 months. Our services allow our clients to take their lead formulation towards commercial success with confidence.

The BDD client base covers the globe and includes USA, Canada, Europe, Japan, India, and Australia. We support businesses from micro virtual labs to small, medium and key global players.

BDD offers a full-service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing, and full technology transfer.

Our patented modified release tablet technology OralogiK™ provides unrivalled control of drug release at the right place and time. This allows our clients to have a tablet designed to their specific modified release needs, including sustained, delayed, multiple pulse and site targeted release.
Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of

ICH GCP-compliant clinical study report. With the ability to run formulation development, GMP manufacture and clinical trials in parallel to ensure a reliable lead formulation is determined.

BDD are world leaders in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time / site of disintegration, gastric emptying, GI transit and intra / inter individual differences.